HEMMUNG VON DIPEPTID-REPEAT-PROTEINEN

European patent · EP3990021 · In force

Register entry

Publication number
EP3990021
Application number
EP20750475
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 8, 2020
Published
May 4, 2022
Granted
Mar 18, 2026
Protection ends at the latest
Jun 7, 2040
Next annual fee due
Jun 30, 2027
IPC classes
A61K 45/00 (2006.01)
A61P 25/28 (2006.01)
A61P 25/14 (2006.01)
A61K 31/40 (2006.01)
A61K 31/445 (2006.01)
A61K 31/4155 (2006.01)
A61K 31/444 (2006.01)
Priority
US 201962868267 P 28.06.2019
US 202063028753 P 22.05.2020
PCT application
PCT/US2020/036643 08.06.2020
PCT publication
WO2020/263550 30.12.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jun 10, 2026

    Agent entered

    Representative
    RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 10.06.2026

  3. Mar 18, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 18.03.2026

Parties

Holder

ALS Therapy Development Institute

300 Technology Square Suite 400, Cambridge, Massachusetts 02139, US

Agent

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

Inventor

VIEIRA, Fernando, G.

Newton, MA 02465, US

PREMASIRI, Alan

Boston, MA 02127, US

GILL, Anna

Reading, MA 01867, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.